國脈科技(002093.SZ):在身聯網的研發與應用過程中 部分採用了ChatGPT、元宇宙、Web3.0中的相關技術
格隆匯2月23日丨國脈科技(002093.SZ)於2023年2月23日在接受特定對象調研時表示,公司持續聚焦身聯網的研發與應用,重視與用户在情感、心理方面的交互,保障用户的隱私及數據的安全性。在身聯網的研發與應用過程中,公司分採用了ChatGPT、元宇宙、Web3.0中的相關技術,用於提供更為智能和沉浸的用户交互體驗,以更高的數據安全性和隱私性,為未來的數據流通、交易做佈局。公司不會侷限於某單一技術的研發與應用,將根據實際需求,不斷將各項前沿技術與身聯網融合,為用户提供精準健康管理服務,真正解決大健康領域的痛點,讓前沿技術貼近民生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.